Previous close | 12.29 |
Open | 12.27 |
Bid | 12.34 x 600 |
Ask | 12.41 x 100 |
Day's range | 12.22 - 12.53 |
52-week range | 8.87 - 18.70 |
Volume | |
Avg. volume | 3,389,588 |
Market cap | 5.2B |
Beta (5Y monthly) | 0.78 |
PE ratio (TTM) | 1,236.00 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
MURRAY, Utah, April 30, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced its management team will present at the 2024 Bank of America Securities Health Care Conference on Thursday, May 16, 2024, at 11:00am ET. A live audio webcast of this presentation will be available on the Investor Relations section of R1’s website at r1rcm.com. A replay
MURRAY, Utah, April 01, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended March 31, 2024, before market open on Wednesday, May 8, 2024 and host a conference call at 8:00 a.m. ET to review the results. Investors and other interested parties are invited to listen to the confere
Report highlights R1’s commitment to corporate responsibility and sustainability across the company’s global footprintMURRAY, Utah, March 27, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, has released its 2023 Environmental, Social and Governance (ESG) report. The report details the company’s commitment to improving access to healthcare, bringing